Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

7,150 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    APHIS Withdraws Proposed Rule On Biotechnology

    In the March 4, 2015, Federal Register, USDA's APHIS withdrew an October 9, 2008, proposed rule that would have changed the federal government's approach toward agricultural biotechnology.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    ARS Intends To Grant Exclusive License

    In the November 5, 2015, Federal Register, USDA's Agricultural Research Service ("ARS") gave notice that it intended to grant to Microarray Equipment & Supplies, LLC of Cupertino, California, an exclusive license...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    Attorney Spotlight: Judith Hasko (Video)

    This Attorney Spotlight features Judith Hasko who joined our Palo Alto office in June 2024 as a partner and co-chair of the Life Sciences practice.
    United StatesFood, Drugs, Healthcare, Life Sciences
    WilmerHale
    WilmerHale
  • Article

    Bacterial Nanowires Represent Breakthrough In Nanotechnology And Bioelectronics

    Researchers at the University of Massachusetts have discovered that a certain bacterium (Geobacter sulfurreducens) contains microbial nanowires capable of transmitting electricity as efficiently as synthetic organic metallic nanostructures.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Day Pitney LLP
    Day Pitney LLP
  • Article

    Bio-Thera And Intas Expand Golimumab Biosimilar Partnership To India

    On March 23, 2026, Bio-Thera Solutions announced an expansion of its existing partnership with Intas Pharmaceuticals for BAT2506, its golimumab biosimilar...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Biogen Seeks Preliminary Injunction In Natilizumab BPCIA Litigation – Hearing Scheduled For May 17

    The parties completed their briefing on Biogen's motion in April, and Judge Williams has scheduled a hearing for May 17 at 1 pm EST.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    BioMEDevice Boston 2018

    On April 19, 2018, Partner Stephen Goodman, Co-Chair of Pryor Cashman's Life Sciences Group, will moderate a panel at the BioMEDevice Boston Conference.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Pryor Cashman LLP
    Pryor Cashman LLP
  • Article

    Celltrion Announces Phase III Results For Aflibercept Biosimilar

    On April 3, 2023, Celltrion announced positive 24-week results from its global Phase III Clinical Trial of CT-P42, a biosimilar referencing Regeneron's EYLEA.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Celltrion Launches STEQEYMA® (ustekinumab-stba) In The United States

    On March 12, 2025, Celltrion announced the commercial launch of STEQEYMA® (ustekinumab-stba), a biosimilar of Janssen's STELARA® (ustekinumab), in the United States.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Class Action Decisions Published April 2025

    Rule 23(b)(3) Damages. In an action challenging The Salvation Army's policy at its adult rehabilitation centers that prevented individuals...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Shook, Hardy & Bacon LLP
    Shook, Hardy & Bacon LLP
  • Article

    CMS Accepting Suggestions For Potential PQRS Measures

    CMS is now accepting quality measure suggestions for potential inclusion in the Physician Quality Reporting System (PQRS) in future years.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS, FDA Establishing Interagency Task Force On LDT Quality Oversight

    CMS and FDA are establishing an interagency task force to reinforce their collaboration regarding the oversight of laboratory-developed tests (LDTs), which are tests intended for clinical use and designed, manufactured, and used within a single lab.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS To Host November 2 Call On Clinical Diagnostic Lab Test Payment System Data Reporting

    CMS is hosting an educational call on November 2, 2016 to discuss reporting obligations under the June 23, 2016 Clinical Diagnostic Test Payment System final rule. As previously reported, under the Protecting Access to Medicare Act (PAMA),
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    Connecticut's $39 Million Award A Bitter Bill For Pharmacy To Swallow

    Connecticut AG William Tong obtained a judgment in his favor in his office's lawsuit against Assured Rx, LLC ("Assured")...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Cozen O'Connor
    Cozen O'Connor
  • Video

    Critical Medical Device Series: Part X Balancing Risk And Innovation: Fraud And Abuse Trends For MedTech (Video)

    This session will provide an overview of the Federal Anti-Kickback Statute, focusing on emerging risks (and mitigation strategies) in the medical device industry.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    CuraTeQ Biologics' Trastuzumab Biosimilar Receives Positive Opinion In Europe

    This week, CuraTeQ Biologics (a wholly owned step-down subsidiary of Aurobindo Pharma Limited) announced that its trastuzumab biosimilar...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Device Recall And Removal Reporting To Become More Efficient

    FDA is streamlining the reporting process for medical device removals and corrections, according to a recent article in "Regulatory Focus".
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Video

    Discussing Myriad & The Supreme Court With LXBN TV

    Following up on my post examining the Myriad gene patenting case, which is heading to the Supreme Court, I had the chance to discuss the subject with Colin O’Keefe of LXBN.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    DOJ False Claims "Working Group" Update

    CYMI over the holiday week (present company included), the U.S. Department of Justice (DOJ) announced a re-energized partnership with the U.S. Department of Health and Human Services (HHS)...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Sheppard
    Sheppard
  • Article

    "Drafting Facility Policies For Returning Explanted Devices: Key Legal And Practical Considerations," By Jennifer L. Weaver And Carol Brass, Journal Of Health & Life Sciences Law, Vol. 7, No. 1

    "Drafting Facility Policies For Returning Explanted Devices: Key Legal And Practical Considerations," By Jennifer L. Weaver And Carol Brass, Journal Of Health & Life Sciences Law, Vol. 7, No. 1.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Waller Lansden Dortch & Davis
    Waller Lansden Dortch & Davis
  • Showing 81–100 of 7150 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics